Clinical Trial: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma
Sponsor and CollaboratorsSingapore General Hospital
ContactContact: Daryl Tan, MBBS MRCP
65-63266604
daryl.tan@sgh.com.sg
Contact: Pei Woon ZN Eng, Bsc (hons)
65-63214627
eng.pei.woon@sgh.com.sg
Principal InvestigatorDaryl Tan, MBBS MRCP Singapore General Hospital
ClinicalTrials.gov IdentifierNCT00901147